China Resources Pharmaceutical Group
3320.HK
#2964
Rank
$4.30 B
Marketcap
$0.68
Share price
-1.84%
Change (1 day)
5.36%
Change (1 year)

Revenue for China Resources Pharmaceutical Group (3320.HK)

Revenue in 2022: $32.52 Billion USD

According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM ) is $32.52 Billion USD. In 2022 the company made a revenue of $32.52 Billion USD an increase over the revenue in the year 2021 that were of $30.36 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for China Resources Pharmaceutical Group from 2013 to 2022

Annual revenue

Year Revenue Change
2022$32.52 B7.09%
2021$30.36 B17.47%
2020$25.85 B-1.52%
2019$26.25 B8.38%
2018$24.22 B9.69%
2017$22.08 B9.28%
2016$20.20 B6.86%
2015$18.91 B8.05%
2014$17.50 B16.04%
2013$15.08 B